Stocks Hitting 52-Week Highs
March 11, 2014 at 10:23 AM EDT
La Jolla Pharmaceutical Co (NASDAQ: LJPC) shares touched a new 52-week high of $18.86 on positive Phase 2 GCS-100 trial results in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.